Pharmasset, Inc. (VRUS)
JP Morgan raised Pharmasset's price target to $200 based on building momentum for the nuc class of Hep C therapies following the recent EASL - Massive upgrade - stock trading 102.55 up 5 in the pre market
Post Market Headlines
United States Oil Fund LP (USO)
GS Raises its year end target for crude to $130/barrel last night
Watch my video "On the Wire"...
View the full post at http://blog.t3live.com
Market News and Data brought to you by Benzinga APIsView the full post at http://blog.t3live.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: BiotechnologyHealth Care
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in